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Abstract
In bacteria, nascent proteins bear the pretranslationally generated N-terminal (Nt) formyl-
methionine (fMet) residue. Nt-fMet of bacterial proteins is a degradation signal, termed fMet/N-
degron. By contrast, proteins synthesized by cytosolic ribosomes of eukaryotes were presumed to 
bear unformylated Nt-Met. Here we found that the yeast formyltransferase Fmt1, although 
imported into mitochondria, could also produce Nt-formylated proteins in the cytosol. Nt-
formylated proteins were strongly up-regulated in stationary phase or upon starvation for specific 
amino acids. This up-regulation strictly required the Gcn2 kinase, which phosphorylates Fmt1 and 
mediates its retention in the cytosol. We also found that the Nt-fMet residues of Nt-formylated 
proteins act as fMet/N-degrons and identified the Psh1 ubiquitin ligase as the recognition 
component of the eukaryotic fMet/N-end rule pathway, which destroys Nt-formylated proteins.
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Graphical Abstract
INTRODUCTION: In both bacteria and eukaryotic mitochondria and chloroplasts, the ribosomal 
synthesis of proteins is initiated with the N-terminal (Nt) formyl-methionine (fMet) residue. Nt-
fMet is produced pretranslationally by formyltransferases, which use 10-formyltetrahydrofolate as 
a cosubstrate. By contrast, proteins synthesized by cytosolic ribosomes of eukaryotes were always 
presumed to bear unformylated N-terminal Met (Nt-Met). The unformylated Nt-Met residue of 
eukaryotic proteins is often cotranslationally Ntacetylated, a modification that creates specific 
degradation signals, Ac/N-degrons, which are targeted by the Ac/N-end rule pathway. The N-end 
rule pathways are a set of proteolytic systems whose unifying feature is their ability to recognize 
proteins containing N-degrons, thereby causing the degradation of these proteins by the 
proteasome or autophagy in eukaryotes and by the proteasome-like ClpAP protease in bacteria. 
The main determinant of an N-degron is a destabilizing Nt-residue of a protein. Studies over the 
past three decades have shown that all 20 amino acids of the genetic code can act, in cognate 
sequence contexts, as destabilizing Nt-residues. The previously known eukaryotic N-end rule 
pathways are the Arg/N-end rule pathway, the Ac/N-end rule pathway, and the Pro/N-end rule 
pathway. Regulated degradation of proteins and their natural fragments by the N-end rule 
pathways has been shown to mediate a broad range of biological processes.
RATIONALE: The chemical similarity of the formyl and acetyl groups and their identical 
locations in, respectively, Nt-formylated and Nt-acetylated proteins led us to suggest, and later to 
show, that the Nt-fMet residues of nascent bacterial proteins can act as bacterial N-degrons, 
termed fMet/N-degrons. Here we wished to determine whether Nt-formylated proteins might also 
form in the cytosol of a eukaryote such as the yeast Saccharomyces cerevisiae and to determine 
the metabolic fates of Nt-formylated proteins if they could be produced outside mitochondria. Our 
approaches included molecular genetic techniques, mass spectrometric analyses of proteins’ N 
termini, and affinity-purified antibodies that selectively recognized Nt-formylated reporter 
proteins.
RESULTS: We discovered that the yeast formyltransferase Fmt1, which is imported from the 
cytosol into the mitochondria inner matrix, can generate Nt-formylated proteins in the cytosol, 
because the translocation of Fmt1 into mitochondria is not as efficacious, even under unstressful 
conditions, as had previously been assumed. We also found that Nt-formylated proteins are greatly 
up-regulated in stationary phase or upon starvation for specific amino acids. The massive increase 
of Nt-formylated proteins strictly requires the Gcn2 kinase, which phosphorylates Fmt1 and 
mediates its retention in the cytosol. Notably, the ability of Gcn2 to retain a large fraction of Fmt1 
in the cytosol of nutritionally stressed cells is confined to Fmt1, inasmuch as the Gcn2 kinase does 
not have such an effect, under the same conditions, on other examined nuclear DNA–encoded 
mitochondrial matrix proteins. The Gcn2-Fmt1 protein localization circuit is a previously 
unknown signal transduction pathway. A down-regulation of cytosolic Nt-formylation was found 
to increase the sensitivity of cells to undernutrition stresses, to a prolonged cold stress, and to a 
toxic compound. We also discovered that the Nt-fMet residues of Nt-formylated cytosolic proteins 
act as eukaryotic fMet/N-degrons and identified the Psh1 E3 ubiquitin ligase as the recognition 
component (fMet/N-recognin) of the previously unknown eukaryotic fMet/N-end rule pathway, 
which destroys Nt-formylated proteins.
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CONCLUSION: The Nt-formylation of proteins, a long-known pretranslational protein 
modification, is mediated by formyltransferases. Nt-formylation was thought to be confined to 
bacteria and bacteria-descended eukaryotic organelles but was found here to also occur at the start 
of translation by the cytosolic ribosomes of a eukaryote. The levels of Nt-formylated eukaryotic 
proteins are greatly increased upon specific stresses, including undernutrition, and appear to be 
important for adaptation to these stresses. We also discovered that Nt-formylated cytosolic 
proteins are selectively destroyed by the eukaryotic fMet/N-end rule pathway, mediated by the 
Psh1 E3 ubiquitin ligase. This previously unknown proteolytic system is likely to be universal 
among eukaryotes, given strongly conserved mechanisms that mediate Nt-formylation and degron 
recognition.
—The eukaryotic fMet/N-end rule pathway.
(Top) Under undernutrition conditions, the Gcn2 kinase augments the cytosolic localization of the 
Fmt1 formyltransferase, and possibly also its enzymatic activity. Consequently, Fmt1 up-regulates 
the cytosolic fMet–tRNAi (initiator transfer RNA), and thereby increases the levels of cytosolic 
Nt-formylated proteins, which are required for the adaptation of cells to specific stressors. 
(Bottom) The Psh1 E3 ubiquitin ligase targets the N-terminal fMet-residues of eukaryotic 
cytosolic proteins, such as Cse4, Pgd1, and Rps22a, for the polyubiquitylation-mediated, protea-
some-dependent degradation.
Nascent proteins bear the N-terminal (Nt) methionine residue, encoded by the AUG 
initiation codon. In bacteria and in eukaryotic mitochondria and chloroplasts, virtually all 
nascent proteins bear the N-terminal formyl-methionine (Nt-fMet), which is generated 
pretranslationally. Formyltransferases (FMTs) use 10-formyltetrahydrofolate as a 
cosubstrate to Nα-terminally formylate the Met moiety of initiator Met-tRNAs. 
Consequently, nascent bacterial proteins bear Nt-fMet (1–7). By contrast, proteins 
synthesized by the cytosolic ribosomes of eukaryotes bear the unformylated Nt-Met residue. 
Kim et al. Page 3
Science. Author manuscript; available in PMC 2019 June 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
This Nt-Met is often Nα-terminally acetylated by Nt-acetylases (8). We have previously 
shown that the cotranslational Nt-acetylation of eukaryotic proteins creates specific 
degradation signals, termed Ac/N-degrons, that are targeted by a distinct N-end rule 
pathway, termed the Ac/N-end rule pathway (fig. S1F) (9–13).
The N-end rule pathways are a set of proteolytic systems whose unifying feature is their 
ability to recognize proteins containing degradation signals called N-degrons, thereby 
causing the degradation of these proteins by the proteasome or autophagy in eukaryotes and 
by the proteasome-like ClpAP protease in bacteria (fig. S1) (9–26). The main determinant of 
an N-degron is a destabilizing Nt-residue of a protein. Initially, most N-degrons are pro–N-
degrons. They are converted to active N-degrons either constitutively (e.g., during the 
emergence of a protein from a ribosome) or conditionally, via regulated steps. Among the 
routes to N-degrons are site-specific cleavages of proteins by proteases such as, for example, 
caspases or calpains, and/or enzymatic Nt-acetylation, Nt-deamidation, Nt-arginylation, or 
Nt-leucylation of specific proteins at the α-amino groups of their Nt-residues (10, 22). 
Studies over the past three decades have shown that all 20 amino acids of the genetic code 
can act, in cognate sequence contexts, as destabilizing Nt-residues (fig. S1). Consequently, 
many proteins in a cell are conditionally short-lived N-end rule substrates, either as full-
length proteins or as protease-generated natural protein fragments. Recognition components 
of N-end rule pathways, called N-recognins, are either E3 ubiquitin (Ub) ligases or other 
proteins that can target N-degrons (10, 22).
Regulated degradation of proteins and/or their fragments by the N-end rule pathways 
mediates a multitude of processes, including the sensing of oxygen, nitric oxide, and heme; 
the control of subunit stoichiometries in protein complexes; the elimination of misfolded 
proteins and also of proteins retrotranslocated to the cytosol from other compartments; the 
regulation of apoptosis and repression of neurodegeneration; the regulation of DNA repair, 
transcription, replication, and chromosome cohesion and segregation; the regulation of 
chaperones, G proteins, cytoskeletal proteins, autophagy, gluconeogenesis, peptide import, 
meiosis, circadian rhythms, fat metabolism, cell migration, immunity, cardiovascular 
development, spermatogenesis, and neurogenesis; and the regulation of leaf development, 
senescence, and many other processes in plants [(10, 18–20, 22) and references therein].
Eukaryotes have been known to contain three N-end rule pathways. One of them is the 
Ac/N-end rule pathway (fig. S1F) (9–13). At least 60 and 80% of nascent proteins in, 
respectively, the yeast Saccharomyces cerevisiae and human cells are cotranslationally and 
irreversibly Nt-acetylated by ribosome-associated Nt-acetylases (8). Many Nt-acetylated 
proteins contain Ac/N-degrons, whose regulation includes their reversible steric shielding in 
cognate protein complexes (11–13, 27).
Another N-end rule pathway is the Arg/N-end rule pathway. It targets unacetylated Nt-
residues (fig. S1G) (10, 14, 15, 28). N-terminal Arg, Lys, His, Leu, Phe, Tyr, Trp, Ile, and 
Met (if Met is followed by a bulky hydrophobic residue) are directly recognized by N-
recognins (12, 29, 30). By contrast, N-terminal Asn, Gln, Glu, and Asp (as well as Cys, 
under some conditions) are destabilizing owing to enzymatic deamidation of Nt-Asn and Nt-
Gln and Nt-arginylation of Nt-Asp and Nt-Glu (25, 26, 31).
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The third eukaryotic N-end rule pathway, termed the Pro/N-end rule pathway, targets 
proteins that bear the Nt-Pro residue or a Pro at position two, in addition to adjoining and 
required sequence motifs (fig. S1E) (20). Physiological substrates of the Pro/N-end rule 
pathway include gluconeogenic enzymes, which are long-lived in cells deprived of glucose 
but are selectively destroyed upon return to glucose-replete conditions (20).
N-terminally formylated proteins in eukaryotic cytosol
In bacteria, the formyl group of Nt-fMet is cotranslationally removed from most (though not 
all) nascent proteins by the ribosome-associated peptide-deformylase (PDF) (2, 3, 5). Some 
fungal and animal genomes, such as those of S. cerevisiae and the nematode Caenorhabditis 
elegans, do not encode proteins that are sequelogous [similar in sequence (32)] to PDFs (6). 
By contrast, the FMTs, which produce fMet-tRNAi from Met-tRNAi are encoded by all 
examined eukaryotic genomes, in addition to being universal among bacteria. Mitochondrial 
FMTs, specified by nuclear DNA, are imported from the cytosol to the inner matrix of 
mitochondria. Consequently, eight proteins that are encoded by the S. cerevisiae 
mitochondrial DNA, are pretranslationally Nt-formylated at the start of their synthesis in the 
matrix and retain the formyl group of their Nt-fMet, in agreement with the (inferred) 
absence of PDF in yeast (6).
Nt-acetylation of eukaryotic proteins creates Ac/N-degrons (fig. S1F) (9–13). The chemical 
similarity of the formyl and acetyl groups and their identical locations in, respectively, Nt-
formylated and Nt-acetylated proteins led us to suggest (9), and later to show (7), that the 
fMet residues at the N termini of nascent bacterial proteins can act as bacterial N-degrons, 
termed fMet/N-degrons (fig. S1C).
Given this function of Nt-fMet in bacteria (7), and also because a eukaryotic FMT enzyme, 
before its import into mitochondria, is transiently cytosolic, we began this study by 
expressing Escherichia coli FMT (EcFMT) in yeast. Such an expression was previously 
shown to convert up to 70% of yeast Met-tRNAi to fMet-tRNAi and to inhibit growth, 
suggesting that Nt-formylated proteins might be generated in the yeast cytosol (4). Our 
initial aim was to address this possibility directly and to determine the metabolic fate of Nt-
formylated proteins if they could be produced outside mitochondria.
EcFMT or vector alone were expressed in yeast from the PGAL1 promoter. Wild-type 
EcFMT (but not its inactive EcFMTR43L mutant; R43L, Arg43→Leu) retarded yeast growth 
(fig. S2B). These assays involved stable-isotope labeling by amino acids in cell culture 
(SILAC), an enrichment for Nt-peptides, and capillary liquid chromatography–tandem mass 
spectrometry (cLC-MS/MS) (fig. S2A). We found that ~11% of nuclear DNA–encoded 
proteins that yielded Nt-peptides analyzable by cLC-MS/MS were Nt-formylated in yeast 
cells that expressed EcFMT. Forty-two Nt-formylated peptides were detected by cLC-
MS/MS, out of 467 distinct Nt-peptides, which were derived from 357 detected proteins (fig. 
S2, A, C, and E, and table S1).
An unexpected result of these analyses was the outcome of controls: In yeast lacking 
EcFMT, ~3% of nuclear DNA–encoded nonmitochondrial proteins contained Nt-fMet (figs. 
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S2, A, C, and D, and S3; and table S1). Thus, notably, proteins containing Nt-fMet were 
synthesized in the yeast cytosol under normal conditions as well. Additional and 
independent evidence for this conclusion is described below.
Nt-formylated proteins in wild-type (lacking EcFMT) yeast that were identified by cLC-
MS/MS were Act1 (actin), Bos1 (a SNAP receptor), Bud27 (a bud site selector), Rps28a and 
Rps28b (ribosomal proteins), Leu2 (3-isopropyl malate dehydrogenase), Sup45 (a peptide 
chain release factor), Dyn2 (a dynein light chain), Uso1 (a vesicle transporter), and Vps52 (a 
vacuolar sorting–associated protein) (figs. S2D and S3). We also detected mitochondrial 
DNA–encoded Cox3, which is produced by mitochondrial ribosomes and thus would be 
expected to bear Nt-fMet, in contrast to nuclear DNA–encoded proteins (figs. S2D and S3G) 
(6).
A parsimonious explanation of these results is that Nt-formylation of nonmitochondrial 
proteins in wild-type (lacking EcFMT) yeast is caused by low but notable cytosolic levels of 
the nuclear DNA–encoded S. cerevisiae Fmt1 (ScFmt1) formyltransferase. In this 
interpretation, the translocation of ScFmt1 from the cytosol (in which ScFmt1 is produced) 
into the mitochondrial matrix (in which ScFmt1 normally resides) is not as efficient, even 
under unstressful conditions, as had previously been assumed. Consequently, enough 
ScFmt1 would be present in the cytosol to cause the formation of cytosolic fMet-tRNAi and 
the pretranslational Nt-formylation of cytosolic proteins (fig. S2D and tables S1 and S2). 
This explanation was found to be correct—the levels of an Nt-formylated Nt-fMet reporter 
became negligible in fmt1Δ yeast (Fig. 1, B and D; see below for details).
Given the pretranslational synthesis of fMet-tRNA, one would expect, a priori, a uniform 
“partitioning” of the Nt-fMet residues among all or most proteins of a cell’s proteome. We 
do not understand why the actual mass spectrometry (MS)–based results (figs. S2, D and E, 
and S3; and tables S1 and S2) are different from this expectation, that is, why only some 
proteins were detected as (partially) Nt-formylated ones. Plausible explanations include an 
incomplete cLC-MS/MS–mediated coverage of the proteome, different rates of degradation 
of specific Nt-formylated proteins, and/or that the efficiency of translation initiation with 
fMet-tRNAi is not the same for all proteins synthesized in the cytosol.
Antibody to N-terminally formylated protein reporters
The 33-kDa reporter, denoted as MD-D2-eK-ha-GST, was identical to our previously 
characterized reporter MD-D2-eK-ha-Ura3, save for the glutathione transferase (GST) 
moiety, used alternately with Ura3 (7). The reporter comprised the Nt-sequence 
MDIAIGTYQEK [denoted as MD-D2 (7)], followed by a 44-residue sequence eK [extension 
(e) containing lysine (K)], by the ha epitope (YPYDVPDYA), by the AFLGQ linker (9), and 
by either GST or Ura3 (Figs. 1A and 2B). The eK segment is often used in reporters because 
it is unstructured (disordered) while lacking degrons in E. coli and yeast (10). MD-D2-GST 
was identical to MD-D2-eK-ha-GST save for the absence of the eK-ha segment (Fig. 1B). 
(Single-letter abbreviations for amino acid residues are as follows: A, Ala; C, Cys; D, Asp; 
E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, 
Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.)
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Cycloheximide (CHX)–chases with MD-D2-eK-ha-Ura3 or MD-D2-eK-ha-GST showed that 
these reporters were short-lived in wild-type S. cerevisiae but were nearly completely stable 
in double-mutant naa20Δ ubr1Δ cells that lacked both the NatB (Naa20) Nt-acetylase and 
the Arg/N-end rule pathway (owing to the absence of Ubr1) (fig. S4, A and B). The naa20Δ 
mutation abrogated the otherwise expected Nt-acetylation, by NatB, of MD-D2-eK-ha–based 
reporters and thereby precluded their degradation by the Ac/N-end rule pathway (8–13). 
Given the stability of MD-D2-eK-ha–based reporters in naa20Δ ubr1Δ cells (fig. S4, A and 
B), most degradation assays were performed in this genetic background.
To detect Nt-fMet by a method independent of mass spectrometry, the synthetic Nt-
formylated peptide fMDIAIGTYQEK (the fMD-D2 moiety; Fig. 1, A and B) was used to 
produce an affinity-purified rabbit antibody, termed anti–MD-D2fM, which recognized the 
above Nt-formylated peptide and also fMD-D2-GST but did not recognize their 
unformylated or Nt-acetylated counterparts (Fig. 1E). Nt-formylated and unformylated MD-
D2-GST were produced in E. coli that were either incubated or not incubated with actinonin, 
an inhibitor of PDF-mediated deformylation (5). The presence of Nt-fMet or unformylated 
Nt-Met in MD-D2-GST was verified using both MS and anti–MD-D2fM antibody (Fig. 1F 
and fig. S5).
SDS–polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting with anti–MD-
D2fM detected Nt-formylated fMD-D2-GST in extracts from EcFMT-expressing yeast (Fig. 
1, B and G). More sensitive immunoprecipitation-immunoblotting assays could also detect 
fMD-D2-GST in extracts from yeast that lacked EcFMT (Fig. 1D). The specificity of anti–
MD-D2fM (Fig. 1, E and F) was also confirmed by observing the quenching of 
immunoblotting signal by the Nt-formylated fMD-D2 peptide but not by its unformylated 
counterpart (Fig. 1G).
In cells expressing MD-D2-GST, the Nt-fMet residue of fMD-D2-GST was generated 
pretranslationally (see introduction) (Fig. 1B). By contrast, MD-D2-GST was generated 
cotranslationally from Ub-MD-D2-GST (bearing the Nt-Ub moiety) upon the cleavage-
mediated removal of Nt-Ub by deubiquitylases (Fig. 1C) (10). Whereas directly expressed 
MD-D2-GST could be readily detected (using anti–MD-D2fM) as the Nt-formylated fMD-
D2-GST species, no Nt-fMet was detected in MD-D2-GST* that resulted from 
deubiquitylation of Ub-MD-D2-GST (the asterisk of MD-D2-GST* denotes its distinct 
origin) (Fig. 1, C and G). Besides confirming the specificity of anti–MD-D2fM, these results 
indicated the pre-translational (at the level of fMet-tRNAi) origin of the Nt-fMet moiety of 
fMD-D2-GST. In addition, coexpression of EcFMT and E. coli PDF (EcPDF) (but not of its 
inactive mutant) in yeast strongly down-regulated the Nt-formylated fMD-D2-GST (Fig. 
1G), in agreement with the (inferred) absence of PDF in S. cerevisiae (6).
Selective degradation of Nt-formylated proteins
The expression of EcFMT in yeast resulted in rapid degradation of the otherwise long-lived 
MD-D2-eK-ha-Ura3 and MD-D2-eK-ha-GST (Fig. 2, A to D, and fig. S4, E to I). By 
contrast, no discernible degradation of MD-D2-eK-ha-Ura3 or MD-D2-eK-ha-GST occurred 
upon expression of the inactive EcFMTR43L mutant or vector alone (Fig. 2, C and D, and fig. 
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S4, E, F, and H). The EcFMT-induced degradation of MD-D2-eK-ha-GST and MD-D2-eK-
ha-Ura3 in yeast was nearly abolished by coexpression of the EcPDF but not of its inactive 
EcPDFE134A mutant (Fig. 2, B and E, and fig. S4G).
Increasing the levels of EcFMT, using the incrementally stronger yeast promoters PADH1, 
PTEF1, and PTDH3, progressively destabilized MD-D2-eK-ha-GST, in part by decreasing its 
prechase (time-zero) levels (fig. S4H). By contrast, the expression of inactive EcFMTR43L 
had no effect (fig. S4H). EcFMT did not discernibly alter the rate of protein synthesis in S. 
cerevisiae, in comparison to expression of inactive EcFMTR43L (fig. S6, A and B).
Tandem Ub-binding entity (TUBE)–pulldowns showed that MD-D2-eK-ha-GST was 
polyubiquitylated in yeast upon expression of EcFMT (but not of inactive EcFMTR43L), 
suggesting that the degradation of Nt-formylated fMD-D2-eK-ha-GST was Ub-dependent 
(Fig. 2F). Assays with MG132, a proteasome inhibitor, indicated that the degradation of 
fMD-D2-eK-ha-GST was also proteasome-dependent (fig. S4I). Importantly, the use of anti–
MD-D2fM showed that the EcFMT-induced degradation of MD-D2-eK-ha–based fusions 
involved, selectively, their Nt-formylated subsets (fig. S4I).
Together, these results (Figs. 1 and 2, and figs. S2 and S4) indicated that the EcFMT-
mediated production of fMet-tRNAi in the yeast cytosol causes the synthesis of Nt-
formylated proteins, which are rapidly degraded. This degradation required the Nt-fMet 
residue of an Nt-formylated protein because the protein could be stabilized by coexpression 
of the active (but not inactive) EcPDF (Fig. 2E and fig. S4G).
We conclude that the Nt-fMet residues of proteins in a eukaryotic cell could act as specific 
degradation signals, termed fMet/N-degrons. The bulk of these results were obtained with S. 
cerevisiae that ectopically expressed EcFMT. Crucially, however, a minor, but discernible, 
fraction of nuclear DNA–encoded nonmitochondrial yeast proteins contained Nt-fMet even 
in S. cerevisiae that did not express EcFMT (figs. S2D and S3, and tables S1 and S2).
Degradation of Nt-formylated proteins requires the Psh1 E3 ubiquitin ligase
Given these results, we screened a collection of single-mutant S. cerevisiae strains that 
lacked specific E3 Ub ligases and expressed both EcFMT and MD-D2-eK-ha-GST. (EcFMT 
was used to augment the synthesis of Nt-formylated proteins.) Extracts from 78 mutant 
strains were fractionated by SDS-PAGE and immunoblotted with anti-ha, anti–MD-D2fM, 
and anti-tubulin (fig. S7). Anti-ha detected all species of MD-D2-eK-ha-GST, whereas anti–
MD-D2fM selectively detected fMD-D2-eK-ha-GST. The Nt-formylated fMD-D2-eK-ha-
GST (relative to total MD-D2-eK-ha-GST) was strongly increased in the psh1Δ mutant, 
implying the in vivo stabilization of fMD-D2-eK-ha-GST in the absence of Psh1 (fig. S7A, 
lane 10).
Nt-formylated fMD-D2-eK-ha-GST was also increased in three other E3 mutants (figs. S7A, 
lane 13; S7D, lane 9; and S7F, lane 11). However, those increases were much less than the 
one in psh1Δ cells and were also accompanied by higher levels of total MD-D2-eK-ha-GST, 
in contrast to the strong and selective increase of fMD-D2-eK-ha-GST in psh1Δ cells (fig. 
S7A, lane 10). In agreement with this screen (fig. S7), the degradation of fMD-D2-eK-ha-
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GST required the Psh1 E3 (Fig. 3A). In addition, the polyubiquitylation of MD-D2-eK-ha-
GST was nearly abolished in psh1Δ yeast, despite the presence of EcFMT (Fig. 2F, lane 4).
The levels of mRNA encoding MD-D2-eK-ha-GST were approximately equal in PSH1 
versus psh1Δ yeast (fig. S8A). Furthermore, C-terminally flag-tagged Psh1 (Psh1f) 
interacted with the Nt-formylated fMD-D2-GST but not with its unformylated counterpart, 
indicating that physical binding by the Psh1 E3 required the Nt-formyl group of fMD-D2-
GST (Fig. 3B).
We conclude that Psh1 is an N-recognin, termed the fMet/N-recognin, of a eukaryotic N-end 
rule pathway, termed the fMet/N-end rule pathway (fig. S1B). Psh1 is a 406-residue RING-
type E3 Ub ligase that acts together with the Ubc8 or Ubc3 E2 enzymes (33–36). In EcFMT-
expressing yeast, the degradation of fMD-D2-eK-ha-GST was comparably efficacious in 
UBC8 and ubc8Δ cells (fig. S8C). By contrast, fMD-D2-eK-ha-GST was stabilized in a 
temperature-sensitive Ubc3 (Ubc3ts) mutant at nonpermissive temperature, indicating that 
the Psh1 fMet/N-recognin mediates the fMet/N-end rule pathway largely together with the 
Ubc3 E2 (figs. S1B and S8B).
Nt-formylation of the Cse4 histone accelerates its Psh1-mediated 
degradation
Until now, the sole known physiological substrate of Psh1 was Cse4 (called CENP-A in 
mammals), the centromere-specific histone H3 variant whose degradation is both Psh1-
dependent and proteasome-dependent (33–37). Using the same approach that yielded anti–
MD-D2fM, we produced an antibody, termed anti-Cse4fM, that selectively recognized the Nt-
formylated fMet-Cse4 (fig. S4, C and D). C-terminally ha-tagged Cse4 (Cse4ha) was 
strongly destabilized, in a Psh1-dependent manner, in wild-type yeast that expressed EcFMT 
(but not its inactive EcFMTR43L mutant) (Fig. 3, C and D, and fig. S8H).
Recognition of Cse4 by Psh1 involves the CENP-A targeting domain (CATD) of Cse4 (Fig. 
3C) (34, 35). To address the targeting of Cse4 through its Nt-fMet residue versus the CATD, 
we replaced CATD with the loop 1–α2 helix of the histone fold domain (HFD) of the main 
histone H3 (34), yielding a chimeric Cse4haHFD protein. In the absence of EcFMT, Cse4haHFD
was longer-lived than Cse4ha, but both Cse4ha
HFD
 and Cse4ha were strongly destabilized in 
yeast that expressed the active (but not inactive) EcFMT (Fig. 3, C and D, and fig. S8E). 
Immunoblotting with anti-Cse4fM confirmed the Nt-formylation of Cse4ha
HFD
 in the presence 
of EcFMT (fig. S4D). In agreement with these results, Cse4haHFD, which was short-lived in 
EcFMT-expressing wild-type yeast, was stabilized either by coexpression of the EcPDF or 
by ablation of the yeast Psh1 E3 (Fig. 3, D and E, and fig. S8E). Cse4haHFD was also stabilized 
in yeast Ubc3ts cells (but not in ubc8Δ cells) at nonpermissive temperature, again indicating 
that Ubc3 is the main E2 of the Psh1-mediated fMet/N-end rule pathway (fig. S8, E and F).
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Psh1-mediated targeting of fMet/N-degrons in proteins other than Cse4
Thus far, 42 yeast proteins have been identified, by cLC-MS/MS, as those that are partially 
Nt-formylated in EcFMT-expressing S. cerevisiae (fig. S2E). We asked whether some of 
these proteins were metabolically unstable, and, if so, whether the bulk of their degradation 
required both Nt-formylation and the Psh1 Ub ligase.
Forty-one proteins (all except Leu2) (fig. S2E) were C-terminally ha tagged and analyzed by 
CHX-chases in PSH1 and psh1Δ yeast cells that expressed EcFMT. Anti-ha cannot 
distinguish between Nt-formylated and unformylated versions of these proteins. Observing 
the degradation of a protein that was dependent on both the Psh1 E3 and EcFMT would 
indicate that a large fraction of the protein’s molecules contained Nt-fMet. Out of 41 
proteins examined, these assays identified two proteins, Pgd1 and Rps22a, whose 
degradation required both Psh1 and EcFMT (fig. S6, C to H), similarly to the Cse4 histone 
(Fig. 3, C to E, and fig. S8, E to H).
Pgd1 is a subunit of the Mediator complex that functions together with RNA polymerase II 
(38). Degradation of Pgd1 required both EcFMT and the Psh1 E3 and could be counteracted 
by coexpression of the EcPDF (but not of its inactive mutant) (fig. S6D). Similar results 
were obtained with the ribosomal protein Rps22a (fig. S6H). The other 39 proteins, which 
were also partially Nt-formylated in EcFMT-expressing yeast (fig. S2E), yielded negative 
results (an example, with Hxk1, is shown in fig. S6I).
Thus, although Nt-formylated versions of the above proteins in EcFMT-expressing yeast 
could be detected by cLC-MS/MS (fig. S2E), the relative levels of Nt-formylated proteins, 
vis-à-vis their unformylated counterparts, would be too low for observing degradation of Nt-
formylated species using anti-ha, which did not distinguish between Nt-formylated and 
unformylated versions of these proteins. Another, not mutually exclusive explanation would 
be the conditionality of fMet/N-degrons in these endogenous (not overexpressed) proteins, 
owing to a rapid posttranslational shielding (sequestration) of their fMet/N-degrons. The 
shielding would occur through an intramolecular protein folding and/or through formation of 
oligomeric protein complexes. This mechanism of conditionality has been demonstrated for 
Ac/N-degrons in proteins whose degradation by the Ac/N-end rule pathway could be halted 
in the presence of their natural protein ligands (11).
Psh1-mediated destruction of Nt-formylated proteins counteracts their 
toxicity
Slow growth of EcFMT-expressing S. cerevisiae could be rescued by expression of EcPDF 
but not of its inactive mutant (4). Because the levels of Nt-formylated proteins are increased 
in EcFMT-expressing yeast (Fig. 1G; fig. S2, C to E; and table S1), and because the Psh1 Ub 
ligase mediates the degradation of Nt-formylated proteins (Fig. 3, A, B, and D; and figs. S6, 
C, E, and F, and S8, E, G, and H), an ablation of Psh1 would be expected to make cells 
hypersensitive to Nt-formylated proteins. In agreement with this prediction, the growth 
defect of EcFMT-expressing yeast was notably higher in psh1Δ cells, either on plates or in 
liquid cultures (fig. S9). Deformylation of Nt-formylated proteins, through a coexpression of 
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EcPDF (but not of its inactive mutant), nearly abolished the growth-rate difference between 
PSH1 and psh1Δ cells that expressed EcFMT (fig. S9B).
These (fig. S9) and other results (see below) implied an increase in steady-state levels of Nt-
formylated proteins both in psh1Δ cells and in stationary-phase wild-type cells. We 
performed additional SILAC-based cLC-MS/MS surveys (as described above and in fig. S2), 
but this time without ectopic EcFMT, and with stationary-phase wild-type cells versus 
stationary-phase psh1Δ cells. This set of MS/MS analyses, with cells not expressing EcFMT, 
identified 21 Nt-formylated proteins in wild-type yeast and 26 Nt-formylated proteins in 
psh1Δ yeast, with both cultures in stationary phase (table S2).
Up-regulation of Nt-formylated proteins upon starvation for specific amino 
acids
Similarly to the effect of expressing EcFMT in S. cerevisiae, an expression, also in yeast, of 
ScFmt1Δ1–26, a derivative of the yeast ScFmt1 that lacked its mitochondrial presequence, 
increased the levels of Nt-formylated fMD-D2-GST (fig. S8D). The levels of Nt-formylated 
fMD-D2-GST were further increased when yeast cultures expressing ScFmt1Δ1–26 reached 
the stationary phase, despite the presence of the fMet/N-end rule pathway in these cells (Fig. 
4A and fig. S1B).
A strong increase of Nt-formylated fMD-D2-GST was also observed with wild-type 
stationary-phase yeast, that is, with cells that expressed neither EcFMT nor the presequence-
lacking ScFmt1Δ1–26 (Fig. 4B). By contrast, no Nt-formylated fMD-D2-GST was present in 
fmt1Δ yeast under any growth conditions (Figs. 1D and 4B). These results were an 
independent confirmation of the cLC-MS/MS findings that the endogenous wild-type 
ScFmt1, though normally imported into mitochondria, also mediated the synthesis of Nt-
formylated cytosolic proteins (fig. S2D and tables S1 and S2).
We wished to identify other stresses, more specific than stationary phase, that could up-
regulate Nt-formylated proteins. To facilitate the detection of Nt-formylated fMD-D2-GST 
by anti–MD-D2fM, wild-type ScFmt1 was moderately over-expressed from a low-copy 
plasmid and the constitutive PTDH3 promoter in psh1Δ S. cerevisiae, which lacked the 
fMet/N-end rule pathway and could not degrade Nt-formylated proteins.
Nt-formylated fMD-D2-GST was greatly up-regulated when yeast cells (auxotrophic for 
His, Lys, Leu, and Trp) were transferred, for 24 hours, to synthetic media lacking His or Lys 
(Fig. 4E). By contrast, starvation for Leu alone or Trp alone did not produce a similar effect 
(Fig. 4E). Furthermore, decreases of His in the medium could incrementally up-regulate Nt-
formylated fMD-D2-GST, in contrast to similar decreases of Trp, which did not alter the 
(initially low) level of fMD-D2-GST (Fig. 4, F and G). Nt-formylated fMD-D2-GST was 
up-regulated upon starvation for His (in yeast that expressed either wild-type ScFmt1 or the 
cytosol-localized ScFmt1Δ1–26) even in PSH1 cells, which contained the fMet/N-end rule 
pathway and could degrade Nt-formylated proteins (Fig. 4, H and I).
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Up-regulation of Nt-formylated fMD-D2-GST in stationary-phase cells or upon starvation 
for His was completely abolished in gcn2Δ cells, which lacked Gcn2, a stress-activated 
multi-functional protein kinase (Fig. 4, J and K). Even the much stronger increase, at 
stationary phase, of Nt-formylated fMD-D2-GST in psh1Δ cells (which could not destroy 
Nt-formylated proteins) was completely abolished in double-mutant gcn2Δ psh1Δ cells that 
lacked both Psh1 and Gcn2 (Fig. 4J).
Further analyses of the Gcn2 effect (Fig. 4, J and K) used Phos-tag, a phosphate-binding 
compound that can be linked to polyacrylamide and thereby selectively “gel shift” 
phosphorylated proteins, relative to their unphosphorylated (or less phosphorylated) 
counterparts. Phosphorylation of ScFmt1myc (ScFmt1 bearing a C-terminal myc tag) was 
substantially increased upon starvation for His in wild-type cells but did not increase in 
gcn2Δ cells (fig. S10B). Thus, large increases of Nt-formylation in the yeast cytosol upon 
specific starvation stresses involved the Gcn2-mediated phosphorylation of ScFmt1, a 
modification that may also regulate the enzymatic activity of ScFmt1 and/or its cytosolic 
localization, as described below.
Starvation increases the Gcn2-dependent cytosolic localization of ScFmt1
Localization of ScFmt1 was analyzed using cells expressing, from a low-copy plasmid and 
the native PFMT1 promoter, either “wild-type” ScFmt1-EGFP3 (bearing three C-terminal 
EGFP moieties) or ScFmt1Δ1–26-EGFP3 (lacking the mitochondrial presequence). The 
ScFmt1-EGFP3 fusion was functionally active and was able to rescue the impaired growth of 
fmt1Δ W303 S. cerevisiae on 2% glycerol–containing nonfermentable respiratory medium 
(fig. S10A). As would be expected, in exponentially growing cells [absorbance at 600 nm 
(A600) < 0.8)], the bulk (> 97%) of ScFmt1-EGFP3 was present in mitochondria, whereas 
the presequence-lacking ScFmt1Δ1–26-EGFP3 was distributed throughout the cytosol (Fig. 
4C and fig. S10C). However, in stationary-phase cells, ~35% of wild-type ScFmt1-EGFP3 
became localized in the cytosol, instead of mitochondria, whereas the largely cytosolic 
localization of the ScFmt1Δ1–26-EGFP3 remained unchanged (Fig. 4, C and D, and fig. 
S10C).
In contrast to ScFmt1, other examined mitochondrial matrix proteins, such as Sod2, Ifm1, or 
Cit1, which are also translocated into the matrix from the cytosol, continued to be efficiently 
(>90%) imported into mitochondria even in stationary phase (fig. S11). Most tellingly, and 
in agreement with the above Gcn2-ScFmt1 results, the partitioning of ~35% of ScFmt1 into 
the cytosol in stationary-phase cells was nearly completely abrogated in gcn2Δ cells (Fig. 4C 
and fig. S10C).
Toxicity of deformylation is augmented by low temperature and azide
What might be a biological role(s) of cytosolic Nt-formylated proteins that are produced in 
wild-type S. cerevisiae and are destroyed by the fMet/N-end rule pathway? To address this 
question, we asked whether ectopic expression of EcPDF, and the resulting deformylation of 
Nt-formylated proteins, might increase the sensitivity of cells to specific stressors. (Wild-
type S. cerevisiae lacks a deformylase.) As described above, the ectopic Nt-formylation of 
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yeast proteins, through expression of EcFMT, caused degradation of these proteins by the 
Psh1-mediated fMet/N-end rule pathway, including degradation of the endogenous 
(nonreporter) proteins Pgd1 and Rps22a (fig. S6, C to H).
The same degradation assays but with wild-type yeast (i.e., with cells that lacked ectopic 
EcFMT and contained solely the endogenous ScFmt1) showed that the endogenous Pgd1 
and Rps22a proteins became short-lived in stationary phase, a setting that strongly augments 
Nt-formylation (Fig. 5, A and B). The stationary-phase degradation of Pgd1 and Rps22a 
required Nt-formylation of these proteins because this degradation could be abolished by 
ectopically expressed EcPDF but not by its catalytically inactive mutant EcPDFE134A (Fig. 
5, A and B).
Furthermore, the Nt-formylation-dependent degradation of Pgd1 and Rps22a (Fig. 5, A and 
B) was observed only if yeast were preincubated, as streaked-out cultures on plates, for ~14 
days at 4°C before inoculating cells into synthetic complete (SC) liquid medium for 
stationary-phase degradation assays at 30°C. A shorter, 7-day pre-incubation of yeast at 4°C 
did not suffice for the degradation of Pgd1 and Rps22a to take place. In agreement with 
these (technically robust) findings, ectopic expression of EcPDF, but not of its inactive 
mutant, reproducibly prolonged the lag period (before exponential growth) of wild-type 
yeast in SC liquid medium. This effect only took place if cell growth was measured with 
yeast that had been preincubated at 4°C for 14 days (as described above) before their 
transfers to liquid cultures for growth assays (Fig. 5D). By contrast, no EcPDF-mediated 
growth retardation was observed with cells that had not been preincubated at 4°C or were 
preincubated at 4°C for only 7 days (Fig. 5C and fig. S12A).
Furthermore, the expression of EcPDF (but not of its inactive mutant) in cold-primed yeast 
(preincubated on plates at 4°C for 14 days) rendered cell growth on a galactose-containing 
minimal solid medium markedly hypersensitive to Na-azide, which inhibits cytochrome c 
oxidase, adenosine triphosphate (ATP) synthesis, and plasma membrane permeability. The 
same EcPDF expression, under the same conditions, did not affect cell growth in the 
presence of other respiratory-chain inhibitors, such as antimycin A, oligomycin, or cyanide 
(Fig. 5E and fig. S12B). In addition, EcPDF did not discernibly affect the growth of 
mitochondrial respiratory chain mutants cox5aΔ, coq5Δ, and atp11Δ (fig. S12C).
Together, these findings made it unlikely that the observed toxicity of ectopic cytosolic 
EcPDF (its inactive mutant was nontoxic) stemmed from deformylation of the eight Nt-
formylated mitochondrial matrix proteins that are encoded by mitochondrial DNA in the 
matrix (see introduction). The robust and reproducible dependence of the toxicity of 
deformylation by EcPDF on a sufficiently long (~14 days) preexposure of cells to 4°C 
suggests that natural Nt-formylation of cytosolic eukaryotic proteins may be functionally 
important and potentially beneficial under conditions of specific undernutrition and/or low 
temperatures. Future studies will analyze this temperature effect. In nontropical climes, 
ecological niches of S. cerevisiae would sometimes expose yeast to temperatures near 0°C. 
Because it is likely (but remains to be verified) that Nt-formylation of cytosolic proteins is 
universal among eukaryotes, it would also be interesting to explore Nt-formylation in 
hibernating animals, whose body temperatures can become low in winter.
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Our findings indicate that the observed retention of the (normally mitochondrial) ScFmt1 
formyltransferase in the cytosol of stationary-phase and other starving cells is the cause of 
massive increases of Nt-formylated proteins. As described above, the retention of ScFmt1 in 
the cytosol strictly requires the Gcn2 kinase (Fig. 4, C and D, and fig. S10C). This effect of 
Gcn2 is apparently specific for ScFmt1, because other examined nuclear DNA–encoded 
mitochondrial-matrix proteins were imported into mitochondria of stationary-phase cells, 
despite the presence of Gcn2 (fig. S11). The observed up-regulation of Nt-formylated 
proteins under the above conditions may contribute, in ways that remain to be understood, to 
adaptations of cells to specific undernutrition stresses.
The eukaryotic fMet/N-end rule pathway
We discovered that the Nt-formylation of proteins, a long-known pretranslational protein 
modification previously thought to be confined to bacteria and bacteria-descended 
eukaryotic organelles, can also occur at the start of translation by the cytosolic ribosomes of 
a eukaryote such as S. cerevisiae (Fig. 5F). The Nt-formylation of cytosolic proteins was 
strongly up-regulated upon specific starvation stresses, including stationary phase or 
depletion of some amino acids, such as His or Lys (Fig. 4). Intriguingly, down-regulation of 
cytosolic Nt-formylation (through ectopic expression of deformylase) increased sensitivity 
of cells to specific undernutrition stresses, and/or to a prolonged cold (4°C) stress, and to 
Na-azide (Fig. 5 and fig. S12).
We also discovered that Nt-formylated cytosolic proteins are targeted by the Psh1 E3 Ub 
ligase (together with the Ubc3 E2 enzyme), which acts as the recognition component of the 
previously unknown eukaryotic fMet/N-end rule pathway that destroys Nt-formylated 
proteins (Fig. 5F). In agreement with these results, we also showed that the Psh1 fMet/N-
recognin physically binds to the formyl group of the Nt-fMet residue (Fig. 3B). Nt-
formylation of yeast cytosolic proteins is caused by the endogenous ScFmt1, whose 
translocation from the cytosol to the inner matrix of mitochondria is not as efficient, even 
under normal conditions, as had previously been assumed, and was strongly impaired in 
stationary phase (Fig. 4, C and D, and figs. S10C and S11).
We also discovered that the up-regulation of Nt-formylated cytosolic proteins in starving 
cells strictly requires Gcn2, a stress-activated protein kinase (Fig. 4, J and K). Gcn2 
mediated the stress-induced increase of Nt-formylated proteins by controlling the cytosolic 
localization of the ScFmt1 enzyme and by being essential for ScFmt1 phosphorylation (Fig. 
4, C and D, and fig. S10, B and C). The latter result suggests that Gcn2 may also regulate the 
enzymatic activity of ScFmt1.
Notably, the ability of Gcn2 to retain a large fraction of ScFmt1 in the cytosol of 
nutritionally stressed cells is apparently confined to ScFmt1, inasmuch as Gcn2 does not 
have such an effect, under the same conditions, on other examined nuclear DNA–encoded 
mitochondrial matrix proteins (Figs. 4C and 5F, and figs. S10C and S11). The regulation of 
ScFmt1 by Gcn2 is a specific protein localization circuit.
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Nt-formylation and Nt-acetylation, two mutually exclusive Nt-modifications of proteins, 
generate, respectively, fMet/N-degrons and Ac/N-degrons (fig. S1, B and F). fMet/N-
degrons are recognized by the Psh1 fMet/N-recognin, a component of the fMet/N-end rule 
pathway (fig. S1B). The pretranslational Nt-formylation of Met-tRNAi, by an FMT enzyme 
such as ScFmt1, requires 10-formyltetrahydrofolate as a cosubstrate, whereas the 
cotranslational Nt-acetylation of proteins by Nt-acetylases requires the acetyl coenzyme A 
(Ac-CoA) cosubstrate (Fig. 2A and fig. S1, B and F).
What might be an adaptive (fitness-increasing) value of the Gcn2 kinase–dependent up-
regulation of Nt-formylated proteins? One possibility is that specific physiological 
perturbations, such as some nutritional and/or low-temperature stresses (see above), may 
retain adequate levels of intra-cellular 10-formyltetrahydrofolate (required for Nt-
formylation) while not retaining adequate levels of Ac-CoA (required for Nt-acetylation). 
Under such conditions, an increased Nt-formylation of newly made proteins (through a 
cytosolic retention of formyltransferase) would maintain, owing to the fMet/N-end rule 
pathway, degradation-based protein quality control. As shown previously, in the absence of 
stress, this control is mediated, in part, by the Ac/N-end rule pathway (9–13). In the 
resulting model, the fMet/N-end rule pathway and the Ac/N-end rule pathway are 
functionally complementary, in that the former may assist the latter under metabolic 
conditions that favor Nt-formylation over Nt-acetylation. The fMet/N-end rule pathway (fig. 
S1, A and B) is the fourth eukaryotic N-end rule pathway that was discovered over the past 
three decades. The three previously identified N-end rule pathways are universal among 
eukaryotes (fig. S1, E to G) (9–15, 20). The fMet/N-end rule pathway (Fig. 5F and fig. S1B) 
is likely to be universal as well, given strongly conserved mechanisms that mediate Nt-
formylation and degron recognition.
Materials and methods summary
Yeast strains, plasmids, genetic techniques, and degradation assays
Standard techniques were used for construction of plasmids and strains. Protein degradation 
as-says were performed largely as described (9, 11). Tables S3 to S5 list S. cerevisiae strains, 
plasmids, and PCR primers. See supplementary materials and methods for details.
Mass spectrometric analyses
SILAC and cLC-MS/MS were carried out as described in the supplementary materials and 
methods.
Production of antibodies specific for two Nt-formylated proteins
Nt-formylated peptides and its unformylated counterparts were synthesized by Abfrontier or 
AbClon (Seoul, Republic of Korea). Production and purification of anti–MD-D2fM and anti-
Cse4fM antibodies (Fig. 1, D to G, and fig. S4, C and D) are described in the supplementary 
materials and methods.
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GST-pulldown assays with Psh1
Nt-formylated fMD-D2-GST and its unformylated MD-D2-GST counterpart were produced 
using E. coli in either the presence or absence of actinonin, a deformylase inhibitor. GST-
pulldowns with yeast extracts containing C-terminally flag-tagged S. cerevisiae Psh1 (Psh1f) 
used purified Nt-formylated fMD-D2-GST versus unformylated MD-D2-GST and were 
carried out as described in the supplementary materials and methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Antibody specific for a set of N-terminally formylated reporters.
(A) MD-D2-eK-ha-GST and some of its amino acid sequences. (B) MD-D2-GST, same 
fusion as in (A) but lacking the eK-ha segment. (C) Same fusion as in (B) but including the 
Nt-Ub moiety. (D) fMD-D2-GSTis produced in wild-type yeast. Lane 1, upper panel: MD-
D2-GST was expressed in wild-type (FMT1) S. cerevisiae and was immunoprecipitated (IP) 
from yeast extracts with anti–MD-D2fM antibody (which selectively recognized Nt-
formylated fMD-D2-GST), followed by SDS-PAGE and immunoblotting (IB) with anti-
GST. Lane 2: Same as lane 1 but with fmt1Δ yeast. Lane 3: Same as lane 1 but with Ub-MD-
D2-GST. Lane 4: Same as lane 3 but with fmt1Δ yeast. Lower panel, inputs: Immunoblotting 
with anti-GST. The red asterisk in (C) and (D) indicates a version of the MD-D2-GST fusion 
that was produced through deubiquitylation of Ub-MD-D2-GST. (E) Dot immunoblotting 
with anti–MD-D2fM antibody versus decreasing amounts of the unmodified 
MDIAIGTYQEKC peptide and either its Nt-formylated or its Nt-acetylated counterparts. 
(F) Purified unformylated MD-D2-GST (lane 1) and Nt-formylated fMD-D2-GST (lane 2) 
were subjected to SDS-PAGE and immunoblotting with either anti–MD-D2fM (upper panel) 
or anti-GST (lower panel). (G) Pretranslational Nt-formylation of MD-D2-GST. The upper 
three panels show immunoblots, using anti–MD-D2fM, of SDS-PAGE-fractionated extracts 
from S. cerevisiae that expressed (or did not express) specific proteins indicated above the 
panels (see the main text). Immunoblots a, b, and c with anti–MD-D2fM were performed in 
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the absence or presence of the indicated peptides. Immunoblot d is the same as immunoblot 
a but with anti-GST.
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Fig. 2. Selective in vivo degradation of Nt-formylated proteins.
(A) A diagram of the fMet-mediated cytosolic synthesis and degradation of a GST-based or 
Ura3-based Nt-formylation reporter (relevant to Figs. 2, B to F, and 3A, and to figs. S4, E to 
I). tRNAi, initiator transfer RNA. (B) Diagrams for the expression of EcFMT, EcPDF, or 
MD-D2-eK-ha-Ura3. 1) A high-copy plasmid expressing EcFMT in S. cerevisiae from the 
PGAL1 promoter, 2) a high-copy plasmid expressing EcFMT and EcPDF from the 
bidirectional PGAL1,10 promoter, and 3) a low-copy plasmid expressing MD-D2-eK-ha-Ura3 
(or MD-D2-eK-ha-GST) from the PCUP1 promoter. (C) CHX-chases with MD-D2-eK-ha-
Ura3 in naa20Δ ubr1Δ S. cerevisiae (see the main text) that expressed either vector alone 
(lanes 1 to 4) or EcFMT (lanes 5 to 8). Immunoblotting was performed with anti-ha. (D) 
Same as in (C) but with MD-D2-eK-ha-GST and cells that expressed either EcFMT (lanes 1 
to 4) or its inactive EcFMTR43L mutant (lanes 5 to 8). The graph shows quantification of 
data (three independent pairs of CHX-chases), with mean ± standard error. (E) CHX-chases, 
using anti-ha, with MD-D2-eK-ha-Ura3 in naa20Δ ubr1Δ S. cerevisiae that expressed wild-
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type EcFMT and also expressed either wild-type EcPDF (lanes 3 and 4) or its inactive 
EcPDFE134A mutant (lanes 1 and 2). (F) TUBE-pulldowns with S. cerevisiae expressing (or 
not expressing) either MD-D2-eK-ha-GST or EcFMT or its EcFMTR43L mutant, with anti-
GST immunoblotting, after TUBE-pulldowns. The lower panel shows inputs and 
immunoblotting with anti-GST.
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Fig. 3. The Psh1 E3 Ub ligase as an fMet/N-recognin.
(A) CHX-chases with MD-D2-eK-ha-GST in naa20Δ ubr1Δ S. cerevisiae (see the main text) 
that expressed EcFMT and either contained (lanes 1 to 4) or lacked (lanes 5 to 8) the Psh1 
E3. Immunoblotting with anti–fMD-D2fM. The graph shows quantification of data (three 
independent pairs of CHX-chases), with mean ± standard error. (B) GST-pulldowns with 
purified Nt-formylated fMD-D2-GST versus unformylated MD-D2-GST and extracts of S. 
cerevisiae that expressed Psh1f (see materials and methods). Detection with anti-flag 
(specific for Psh1f), anti-GST, and anti–fMD-D2fM (specific for Nt-formylated fMD-D2-
GST). Lanes 1 to 3 are described in (B). Note specific binding of Psh1f to fMD-D2-GST. 
(C) Wild-type ha-tagged Cse4ha, histone H3, and “hybrid” Cse4haHFD (see the main text). (D) 
CHX-chases with Cse4ha (lanes 1 to 4) and Cse4haHFD (lanes 5 to 10) in S. cerevisiae 
expressing EcFMT or its EcFMTR43L mutant. Lanes 9 and 10 are the same as lanes 5 and 6 
but in psh1Δ yeast. Immunoblotting was performed with anti-ha. (E) CHX-chases of 
Cse4ha
HFD
 in EcFMT-expressing S. cerevisiae that also expressed EcPDF (lanes 1 to 3) or its 
Kim et al. Page 23
Science. Author manuscript; available in PMC 2019 June 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
inactive EcPDFE134A mutant (lanes 4 to 6). The graph shows quantification of data (three 
independent pairs of CHX-chases), with mean ± standard error.
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Fig. 4. Up-regulation of Nt-formylated proteins and cytosolic localization of mitochondrial 
formyltransferase upon starvation in yeast.
(A) S. cerevisiae expressing MD-D2-GST and the mitochondrial presequence–lacking 
ScFmt1 Δ1–26f were grown in SC medium until stationary phase (48 hours), followed by 
SDS-PAGE of cell extracts and detection of Nt-formylated fMD-D2-GST by 
immunoblotting with anti–MD-D2fM. The lower panel shows immunoblotting with anti-
GST. (B) FMT1 (lanes 1 and 2) and ScFmt1-lacking fmt1Δ S. cerevisiae (lanes 3 and 4) 
expressing MD-D2-GST were grown in SC medium from 24 to 72 hours (reaching 
stationary phase), followed by immunoprecipitation of cell extracts with anti–MD-D2fM, 
SDS-PAGE of immunoprecipitates, and immunoblotting with anti-GST (upper panel). The 
lower panel shows immunoblotting with anti-GST, but of total (input) samples.(C) 
Representative images of fluorescent wild-type cells expressing, respectively, the 
presequence-lacking ScFmt1Δ1–26-EGFP3 fusion (two upper squares) and wild-type 
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ScFmt1-EGFP3 (two middle squares). The two bottom squares show gcn2Δ cells expressing 
wild-type ScFmt1-EGFP3. The left and right squares show, respectively, cells in exponential 
growth and in stationary phase. Note the increased cytosolic localization of ScFmt1-EGFP3 
in wild-type cells in stationary phase (middle-right square) but not in stationary-phase gcn2Δ 
cells (bottom-right square). (D) Relative amounts of the cytosolically localized ScFmt1-
EGFP3 in wild-type cells during exponential growth (6-hour growth) and in stationary-phase 
(72-hour growth) wild-type versus gcn2Δ cells. The data are shown as means ± standard 
deviations for ~300 cells in each of three independent experiments. P values of less than 
0.002 were calculated using a two-tailed Student’s t test. (E) Stationary (48 hour; A600 of 
~3.5) cultures of psh1Δ S. cerevisiae (auxotrophic for His, Lys, Leu, and Trp) expressing 
MD-D2-GST and the wild-type flag-tagged ScFmt1f in SC medium were incubated for 
another 24 hours in fresh SC that either contained His, Lys, Leu, and Trp (lane 1) or lacked 
either His, Lys, Leu, or Trp (lanes 2 to 5, respectively). SDS-PAGE of cell extracts was 
followed by immunoblotting with anti–MD-D2fM, anti-GST, and anti-flag. a-acids, amino 
acids.(F) Twenty-four–hour cultures (A600 of ~3.0) of psh1Δ S. cerevisiae (auxotrophic for 
His, Lys, Leu, and Trp) expressing MD-D2-GST and wild-type ScFmt1f were diluted to 
A600 of ~0.1 and thereafter were grown for 48 hours in SC that contained either the standard 
(20 μg/ml) concentration of His (lane 1) or decreasing concentrations of His, as indicated in 
lanes 2 to 5, followed by immunoblotting as described in (E). (G) Same as in (F) but with 
Trp instead of His. (H and I) Twenty-four–hour cultures (A600 of ~3.0) of PSH1 S. 
cerevisiae expressing MD-D2-GST and either wild-type ScFmt1f (H) or ScFmt1f Δ1–26 (I) 
were diluted to A600 of ~0.1 and thereafter were grown for 48 hours in SC containing His at 
either 20 or2 μg/ml, followed by SDS-PAGE of cell extracts and immunoblotting with anti–
MD-D2fM, anti-GST, and anti-flag. (J) S. cerevisiae (A600 of ~3.5), of the indicated 
genotypes, expressing MD-D2-GST and wild-type ScFmt1f, were incubated for another 24 
hours in the absence of added His, followed by analyses described in (E). (K) Wild-type, 
gcn2Δ, and fmt1Δ S. cerevisiae expressing MD-D2-GST were grown in SC to stationary 
phase (for 72 hours) and were analyzed by immunoblotting, as in (B).
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Fig. 5. Toxicity of deformylase is augmented by low temperature and azide.
(A) CHX-chases for 0, 3, and 6 hours with C-terminally ha-tagged Pgd1ha and 48-hour 
culture (stationary phase) of wild-type S. cerevisiae that expressed either EcPDF or its 
catalytically inactive EcPDFE134A mutant. Before these assays in liquid cultures, cells were 
kept as streaked-out cultures on plates for ~14 days at 4°C (see the main text). The graphs 
show quantification of data (three independent pairs of CHX-chases), with mean ± standard 
error. (B) Same as in (A), but CHX-chases were for 0, 6, and 9 hours with Rps22aha. (C) 
Growth (A600) of wild-type yeast in SC medium, measured in 96-well microplates using 
orbital shaker and Epoch 2 microplate spectrophotometer. S. cerevisiae expressed either 
vector alone or EcPDF or its inactive EcPDFE134A mutant and were not preincubated at 4°C. 
Note indistinguishable rates of growth, irrespective of expression of EcPDF. (D) Same as in 
(C) but yeast were kept as streaked-out cultures on plates for 14 days at 4°C [see (A) and the 
main text] before growth assays in liquid culture. Note a discernibly slower growth, with 
preincubation at 4°C, of cells that expressed EcPDF (but not its inactive EcPDFE134A 
mutant). In (C) and (D), each point on the curve also shows ± standard error of A600 values 
(at 10-min intervals), with measurements carried out independently six times. (E) Wild-type 
S. cerevisiae that expressed either vector alone or EcPDF or its inactive EcPDFE134A mutant 
were serially diluted (fivefold) and spotted on galactose-containing minimal medium (SGal) 
plates with or without either 20 μM NaN3 or 20 nM antimycin A. The plates were incubated 
at 30°C for 3 days. As in (A) to (D), yeast cells were kept for ~14 days at 4°C before 16-
hour liquid-culture growth and spot assays. (F) A partial summary of main results. Upon 
specific nutritional stresses (including stationary phase), the ScFmt1 formyltransferase is 
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substantially retained in the cytosol, an alteration that strictly requires the Gcn2 kinase, 
which phosphorylates ScFmt1 and might also increase its enzymatic activity. The effect of 
Gcn2 on the cytosolic retention of ScFmt1 appears to be confined to ScFmt1, that is, it does 
not extend to other nuclear DNA–encoded mitochondrial matrix proteins. The increased 
cytosolic localization of ScFmt1 increases production of cytosolic fMet-tRNAi, and thereby 
up-regulates cytosolic Nt-formylated proteins. The latter are targeted for degradation by the 
Psh1 Ub ligase, the fMet/N-recognin of the proteasome-mediated fMet/N-end rule pathway.
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